Alpha 2.0
Login Register
» Articles » PMID: 2409872

Pharmacological Manipulation of Fetal Hemoglobin Synthesis in Patients with Severe Beta-thalassemia

Overview
Journal Ann N Y Acad Sci
Specialty Science
Date 1985 Jan 1
PMID 2409872
Citations 9
Authors
A W Nienhuis
T J Ley
R K Humphries
N S Young
G Dover
Affiliations
Soon will be listed here.
Citing Articles

and induction of fetal hemoglobin with a reversible and selective DNMT1 inhibitor.

Gilmartin A, Groy A, Gore E, Atkins C, Long E, Montoute M Haematologica. 2020; 106(7):1979-1987.

PMID: 32586904 PMC: 8252945. DOI: 10.3324/haematol.2020.248658.

Natural Remedies for the Treatment of Beta-Thalassemia and Sickle Cell Anemia-Current Status and Perspectives in Fetal Hemoglobin Reactivation.

Ng N, Ko C Int Sch Res Notices. 2016; 2014:123257.

PMID: 27350962 PMC: 4897541. DOI: 10.1155/2014/123257.

Emodin can induce K562 cells to erythroid differentiation and improve the expression of globin genes.

Ma Y, Chen M, Wu Z, Zhao H, Yu H, Yu J Mol Cell Biochem. 2013; 382(1-2):127-36.

PMID: 23744534 DOI: 10.1007/s11010-013-1726-3.

MBD2 contributes to developmental silencing of the human ε-globin gene.

Rupon J, Wang S, Gnanapragasam M, Labropoulos S, Ginder G Blood Cells Mol Dis. 2011; 46(3):212-9.

PMID: 21296012 PMC: 3062199. DOI: 10.1016/j.bcmd.2011.01.001.

Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.

Fathallah H, Taher A, Bazarbachi A, Atweh G Blood Cells Mol Dis. 2009; 43(1):58-62.

PMID: 19346141 PMC: 2707824. DOI: 10.1016/j.bcmd.2009.02.006.